Gloss Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.66 M
as on 31-07-2024
- Paid Up Capital ₹ 2.25 M
as on 31-07-2024
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.66 Cr
as on 31-07-2024
- Satisfied Charges ₹ 0.50 M
as on 31-07-2024
- Revenue 0.33%
(FY 2023)
- Profit 27.15%
(FY 2023)
- Ebitda 6.31%
(FY 2023)
- Net Worth 8.35%
(FY 2023)
- Total Assets 3.51%
(FY 2023)
About Gloss Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.66 M and a paid-up capital of Rs 2.25 M.
The company currently has active open charges totaling ₹2.66 Cr. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Vashistha, Rekha Vashistha, and Vagish Awasthi serve as directors at the Company.
- CIN/LLPIN
U51109UP1997PTC022114
- Company No.
022114
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jun 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Uttar Pradesh, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gloss Pharmaceuticals Private Limited offer?
Gloss Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Common Disease Medicines, Pharmaceutical Capsules, Digestive System Drugs & Medicines, Antacid Drugs, Allopathic Cough Syrup, Pharma & Bioanalytical Services.
Who are the key members and board of directors at Gloss Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Vashistha  | Director | 15-Jun-1997 | Current |
| Rekha Vashistha | Director | 15-Jun-1997 | Current |
| Vagish Awasthi | Additional Director | 01-Apr-2024 | Current |
Financial Performance of Gloss Pharmaceuticals.
Gloss Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.33% increase. The company also saw a substantial improvement in profitability, with a 27.15% increase in profit. The company's net worth moved up by a moderate rise of 8.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gloss Pharmaceuticals?
In 2023, Gloss Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 14 Aug 2020 | ₹0.39 M | Open |
Sidbi Creation Date: 20 May 2020 | ₹5.00 M | Open |
Others Creation Date: 28 Mar 2007 | ₹2.12 Cr | Open |
How Many Employees Work at Gloss Pharmaceuticals?
Unlock and access historical data on people associated with Gloss Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gloss Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gloss Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
